MYELOVAX, liofilizatas geriamajai suspensijai
MYELOVAX, liofilizatas geriamajai suspensijai
Not authorised
- Avian encephalomyelitis virus, strain Calnek 1143, Live
Product identification
Medicine name:
MYELOVAX, liofilizatas geriamajai suspensijai
Active substance:
- Avian encephalomyelitis virus, strain Calnek 1143, Live
Target species:
-
Chicken
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Avian encephalomyelitis virus, strain Calnek 1143, Live1000.00/50% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oral suspension
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken
-
Meat and offal0day
-
Egg0dayDo not vaccinate chickens under 3 weeks of age, laying hens and breeding hens during egg lay.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/99/1008/001-004
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1008.pdf
Lithuanian (PDF)
Download Published on: 14/06/2022
